Actively Recruiting
The Efficacy of Additional Motor Training Dosage During the Early Stages Post Stroke on the Upper Extremity Recovery
Led by Adi Negev-Nahalat Eran · Updated on 2025-07-17
50
Participants Needed
2
Research Sites
104 weeks
Total Duration
On this page
Sponsors
A
Adi Negev-Nahalat Eran
Lead Sponsor
B
Ben-Gurion University of the Negev
Collaborating Sponsor
AI-Summary
What this Trial Is About
Intervention abstract Background: Stroke is the leading cause of long-term disability, and the second leading cause of death in the western world. Most stroke survivors will suffer from motor and cognitive disturbances for the rest of their life, which negatively affects their normal daily life. Despite the decline in stroke-related mortality over the past decades, the outcome of rehabilitation programs does not improve, and is predictable regardless of the program used. Still, several human and animal studies show that high capacity of training in the early stages post stroke improve motor recovery. This notion is far from being well established. Aim: Studying the effect of high-dosage, high-intensity training program in the subacute period on upper extremity motor recovery. Population: Stroke survivors. Study duration: 6 months. Study protocol: Participants will receive additional technology-based upper extremity training for 120 min/day, 5d/w, 4 weeks. They will be monitored pre and post training, and 6 months post-stroke. Outcome measures will include clinical, kinematic and adherence measures (see complete list in the protocol).
CONDITIONS
Official Title
The Efficacy of Additional Motor Training Dosage During the Early Stages Post Stroke on the Upper Extremity Recovery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Ischemic or hemorrhagic stroke (hemispheric or brainstem) confirmed by CT or MRI
- First-ever stroke or previous stroke without upper extremity weakness
- Time after stroke onset between 1 week and 6 weeks
- Active shoulder flexion of at least 20 degrees and partial wrist and/or finger active movement
- Ability to provide informed consent
You will not qualify if you...
- Painful shoulder that limits active forward reach
- Severe spasticity or non-neural loss of range of motion
- Cognitive or communication impairments as determined by the clinical team
- Unstable medical conditions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Adi Negev-Nahalat Eran
Ofakim, Israel
Not Yet Recruiting
2
Adi Negev-Nahalat Eran
Ofakim, Israel
Actively Recruiting
Research Team
G
Gil Meir
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here